{
  "doc_id": "2d78076333191bda346b23c6db3ec086d875bc4de37bca55597c3d5dbbfe9940",
  "chunk_entities": [
    {
      "chunk_id": "d09ff73e20df2dbdce19504cd9c6b5cb",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 cyclic nucleotide phosphodiesterases",
          "context": "The PDE4 cyclic nucleotide phosphodiesterases are essential regulators"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "regulators of cAMP abundance"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "regulate PKA activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB",
          "context": "phosphorylation of CREB"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "PDE4 inhibitors have been shown"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "have antidepressant and memory-enhancing activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory-enhancing activity",
          "context": "antidepressant and memory-enhancing activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "clinically-useful PDE4 inhibitors for CNS disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "CNS disorders",
          "context": "PDE4 inhibitors for CNS disorders"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 enzymes",
          "context": "configuration of PDE4 enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "the \u201clong\u201d PDE4 isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "development of a new generation of PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "act on long PDE4 isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "These next generation PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "RACK1",
          "context": "such as RACK1, \\beta-arrestin, and DISC1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\beta-arrestin",
          "context": "RACK1, \\beta-arrestin, and DISC1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "\\beta-arrestin, and DISC1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "affect cAMP levels"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic plasticity",
          "context": "such as synaptic plasticity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "target PDE4 populations"
        },
        {
          "entity_type": "Effect",
          "entity_name": "learning and memory",
          "context": "implicated in learning and memory, affect, and cognition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "affect",
          "context": "learning and memory, affect, and cognition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognition",
          "context": "affect, and cognition"
        },
        {
          "entity_type": "Disease",
          "entity_name": "affective disorders",
          "context": "include affective disorders, memory enhancement, and neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory enhancement",
          "context": "affective disorders, memory enhancement, and neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenesis",
          "context": "memory enhancement, and neurogenesis"
        }
      ]
    },
    {
      "chunk_id": "2f41660756df8077b225e34df14ab812",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "Keywords cAMP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase",
          "context": "Phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Beta-arrestin",
          "context": "Beta-arrestin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "RACK1",
          "context": "RACK1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK1/2",
          "context": "ERK1/2"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Learning",
          "context": "Learning"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Memory",
          "context": "Memory"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Depression"
        }
      ]
    },
    {
      "chunk_id": "94207ef8c9b8fc504579199265447f14",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "As all PDE4-selective inhibitors act"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 enzymes",
          "context": "catalytic sites of the PDE4 enzymes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "inhibitors of cAMP hydrolysis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "inhibitors",
          "context": "development of inhibitors selective"
        },
        {
          "entity_type": "Compound",
          "entity_name": "compounds",
          "context": "some newer compounds may be more selective"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "most PDE4-selective inhibitors have less than a tenfold difference"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "IC_{50}",
          "context": "potency (i.e., IC_{50})"
        }
      ]
    },
    {
      "chunk_id": "17585205a23ec9e8a39b10d734b85442",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "Long PDE4 isoforms, such as PDE4B1 and PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "Long PDE4 isoforms, such as PDE4B1 and PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR1",
          "context": "interaction between specific regions of UCR1 and UCR2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR2",
          "context": "interaction between specific regions of UCR1 and UCR2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "catalytic domain",
          "context": "interacted with the catalytic domain"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Asp463",
          "context": "electrostatic interactions between Asp463 and Arg499"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Arg499",
          "context": "electrostatic interactions between Asp463 and Arg499"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Asp 471",
          "context": "Asp 471 and Arg507 in PDE4B1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Arg507",
          "context": "Asp 471 and Arg507 in PDE4B1"
        }
      ]
    },
    {
      "chunk_id": "f24cd77f434befb7485fec851ccfbe9a",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "improved tolerability",
          "context": "account for their improved tolerability in inflammatory and pulmonary disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "inflammatory disorders",
          "context": "tolerability in inflammatory and pulmonary disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "pulmonary disorders",
          "context": "tolerability in inflammatory and pulmonary disorders"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "older agents, such as rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "potency",
          "context": "reduces their potency in the CNS"
        },
        {
          "entity_type": "Effect",
          "entity_name": "CNS-selectivity",
          "context": "optimize the CNS-selectivity and effectiveness of PDE4-selective inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "effectiveness",
          "context": "optimize the CNS-selectivity and effectiveness of PDE4-selective inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "effectiveness of PDE4-selective inhibitors"
        }
      ]
    },
    {
      "chunk_id": "1bd60cbc6345bfdc66520f9424dfd68f",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "The functions of PDE4 isoforms are dynamically regulated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "phosphorylation by kinases such as PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK1/2",
          "context": "kinases such as PKA, ERK1/2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MK2",
          "context": "kinases such as PKA, ERK1/2, MK2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPK",
          "context": "kinases such as PKA, ERK1/2, MK2, and AMPK"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ubiquitination",
          "context": "modification by ubiquitination"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sumoylation",
          "context": "modification by ubiquitination and sumoylation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "The activity of all long PDE4 isoforms is increased"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased",
          "context": "activity of all long PDE4 isoforms is increased"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "two- to sixfold",
          "context": "increased by two- to sixfold"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "upon PKA phosphorylation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibited",
          "context": "ability of the enzyme to be inhibited"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "inhibitors, such as rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK1/2",
          "context": "ERK1/2 phosphorylation attenuates PDE activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuates PDE activity",
          "context": "ERK1/2 phosphorylation attenuates PDE activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MK2 kinase",
          "context": "MK2 kinase serves to attenuate"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attenuate the degree of activation",
          "context": "attenuate the degree of activation conferred by PKA phosphorylation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "activation conferred by PKA phosphorylation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "in the case of PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "mono-ubiquitination",
          "context": "site for mono-ubiquitination"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\beta-arrestin",
          "context": "by the \\beta-arrestin-sequestered E3 ligase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "E3 ligase",
          "context": "\\beta-arrestin-sequestered E3 ligase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Mdm3",
          "context": "E3 ligase, Mdm3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "poly-ubiquitination",
          "context": "gates poly-ubiquitination"
        }
      ]
    },
    {
      "chunk_id": "c33fcd1c73a9750ca6fd762f8f49b413",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "effects of phosphorylation on PDE4 dimerization"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "PKA phosphorylates a site"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D3",
          "context": "S54 in PDE4D3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "S126 in PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "S133 in PDE4B1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "QRRES",
          "context": "in the motif QRRES"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR2",
          "context": "N-terminus of UCR2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK1/2",
          "context": "ERK1/2 phosphorylates a site"
        },
        {
          "entity_type": "Compound",
          "entity_name": "catalytic domain",
          "context": "outer surface of the catalytic domain"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MK2",
          "context": "MK2 phosphorylates a serine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "serine",
          "context": "phosphorylates a serine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR1",
          "context": "within UCR1"
        }
      ]
    },
    {
      "chunk_id": "6f9348c4f2c86e2dd7280a636abd9a1a",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "inhibit dimerization",
          "context": "their protein partners would restrict access to these surfaces and thereby inhibit dimerization."
        },
        {
          "entity_type": "Effect",
          "entity_name": "blocking dimerization",
          "context": "the dimerization of PDE4D5 was blocked by two well-characterized protein partners"
        },
        {
          "entity_type": "Effect",
          "entity_name": "preventing it from forming a dimer",
          "context": "possibly by sequestering the monomeric protein and thereby preventing it from forming a dimer"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibiting the dimerization",
          "context": "Inhibiting the dimerization of PDE4D5 could have multiple possible functional roles"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increasing the enzymatic activity",
          "context": "such as increasing the enzymatic activity of PDE4D5 in certain cellular contexts"
        }
      ]
    },
    {
      "chunk_id": "c418126e5189e05c5e8be5ddd9686294",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "RACK1",
          "context": "RACK1 and \u03b2-arrestin2 have very different avidities"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\u03b2-arrestin2",
          "context": "RACK1 and \u03b2-arrestin2 have very different avidities"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "conformation of PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GRK2",
          "context": "GRK2-phosphorylated state"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\u03b2_2-adrenergic receptor",
          "context": "state of the \u03b2_2-adrenergic receptor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "down-regulate cAMP signaling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "down-regulate cAMP signaling",
          "context": "thereby down-regulate cAMP signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "move PDE4 enzymatic activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "catalytic activity",
          "context": "much higher catalytic activity"
        }
      ]
    },
    {
      "chunk_id": "0f435dcc974c23755811135ecd26ddfa",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4s",
          "context": "functions of the PDE4s"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "that cAMP binds to"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-dependent protein kinase",
          "context": "subunit of cAMP-dependent protein kinase (kinase A; PKA)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "kinase A; PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Epac",
          "context": "activated by cAMP (Epac"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-gated ion channels",
          "context": "cAMP-gated ion channels"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rap1",
          "context": "factor for Rap1"
        }
      ]
    },
    {
      "chunk_id": "51dcc37a1ef9c2c62c09059421e5a3b3",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "cAMP can regulate ion channel activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "phosphorylated by PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cystic fibrosis transmembrane regulator (CFTR)",
          "context": "the cystic fibrosis transmembrane regulator (CFTR)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cl-",
          "context": "a Cl- ion channel"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cystic fibrosis",
          "context": "mutated in the disease cystic fibrosis"
        }
      ]
    },
    {
      "chunk_id": "aaa3ec3577f8999b88c34744a54a7b76",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "A number of PDE4 isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "other than PDE4B1"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic function",
          "context": "implicated in synaptic function"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hippocampal functions",
          "context": "in hippocampal functions"
        },
        {
          "entity_type": "Effect",
          "entity_name": "learning",
          "context": "essential to learning"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory",
          "context": "learning and memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B3",
          "context": "the PDE4B3 isoform"
        },
        {
          "entity_type": "Effect",
          "entity_name": "LTP",
          "context": "implicated in LTP"
        },
        {
          "entity_type": "Effect",
          "entity_name": "late-phase LTP",
          "context": "especially late-phase LTP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "gravin",
          "context": "anchoring protein gravin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "containing PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKC",
          "context": "PKC, calmodulin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "calmodulin",
          "context": "calmodulin, and PDE4D isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D isoforms",
          "context": "and PDE4D isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\beta_2-adrenergic receptor",
          "context": "to the \\beta_2-adrenergic receptor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "gravin",
          "context": "alpha-isoform of gravin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "PKA-dependent long-lasting forms"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hippocampal synaptic plasticity",
          "context": "forms of hippocampal synaptic plasticity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\beta_2-adrenergic receptor",
          "context": "\\beta_2-adrenergic receptor-mediated plasticity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "long-term memory storage",
          "context": "impairments of long-term memory storage"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "different PDE4 isoforms"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic plasticity",
          "context": "in synaptic plasticity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "learning",
          "context": "in learning and memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory",
          "context": "learning and memory"
        }
      ]
    },
    {
      "chunk_id": "851f753fe138eae49cdef934513e841b",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "role of PDE4 isoforms"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depression",
          "context": "in depression and learning"
        },
        {
          "entity_type": "Effect",
          "entity_name": "learning",
          "context": "in depression and learning"
        },
        {
          "entity_type": "Disease",
          "entity_name": "sleep disorders",
          "context": "sleep and sleep disorders"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory consolidation",
          "context": "role of sleep in memory consolidation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory loss",
          "context": "produce memory loss"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "impairment of cAMP- and PKA-dependent forms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "impairment of cAMP- and PKA-dependent forms"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic plasticity",
          "context": "hippocampal synaptic plasticity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "increases PDE4 activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory consolidation deficits",
          "context": "prevents memory consolidation deficits"
        },
        {
          "entity_type": "Effect",
          "entity_name": "PDE4 inhibition",
          "context": "benefit of PDE4 inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognition",
          "context": "on cognition and memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory",
          "context": "on cognition and memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "as rolipram and other PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "rolipram and other PDE4 inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognitive function",
          "context": "improve cognitive function"
        }
      ]
    },
    {
      "chunk_id": "ce773262d6a8b4e0215039826bd9fc98",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "The prototypical PDE4 inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitor",
          "context": "The prototypical PDE4 inhibitor rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like activity",
          "context": "its antidepressant-like activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitor",
          "context": "a highly-selective PDE4 inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Extensive testing of rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "numerous other PDE4-selective inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "tricyclic antidepressants",
          "context": "such as tricyclic antidepressants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SSRIs",
          "context": "SSRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "SNRIs",
          "context": "SNRIs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "Specifically, PDE4-selective inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like activity",
          "context": "have antidepressant-like activity"
        }
      ]
    },
    {
      "chunk_id": "9f565370dbc85702b0849cc5b49404ee",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4-selective inhibitors",
          "context": "These side effects of PDE4-selective inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "gastric acid production",
          "context": "gastric acid production and secretory diarrhea"
        },
        {
          "entity_type": "Effect",
          "entity_name": "secretory diarrhea",
          "context": "gastric acid production and secretory diarrhea"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "elevation of cAMP levels"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "side effects of PDE4 inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emesis",
          "context": "experimental studies of emesis"
        }
      ]
    },
    {
      "chunk_id": "43b8deb8b07bea5fff2ae516fb348a6f",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "siRNA",
          "context": "lentiviruses expressing siRNA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoform",
          "context": "knock down a specific PDE4 isoform"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4d",
          "context": "the Pde4d is essential to memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "regulation of pCREB"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4d siRNA",
          "context": "Pde4d siRNA also has a profound effect"
        }
      ]
    },
    {
      "chunk_id": "cc972404102f640556454b60c430e9a2",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1 mutant",
          "context": "used the over-expression of a dominant-negative PDE4B1 mutant as a transgene"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 mutants",
          "context": "used dominant-negative PDE4 mutants successfully in cell-based studies"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoform",
          "context": "displace the corresponding endogenous PDE4 isoform from its protein partner(s)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4b",
          "context": "The murine Pde4b and human PDE4B gene both encode five isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B gene",
          "context": "The murine Pde4b and human PDE4B gene both encode five isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B isoforms",
          "context": "deficiency of all five PDE4B isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "effect(s) of any individual isoform, such as PDE4B1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA RI\\alpha subunit",
          "context": "expressed a dominant-negative PKA RI\\alpha subunit"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB mutant",
          "context": "or a dominant-negative CREB mutant"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CaMKII\\alpha promoter",
          "context": "expressed off the CaMKII\\alpha promoter"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1 isoform",
          "context": "target just the PDE4B1 isoform"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4b",
          "context": "specificity than a Pde4b knockout"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "phenotype in PDE4B1 dominant-negative mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4b-/-",
          "context": "compared to Pde4b-/- mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "The PDE4B1 dominant-negative transgene clearly produces increased activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "levels of pCREB and neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased activity",
          "context": "produces increased activity, levels of pCREB and neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenesis",
          "context": "levels of pCREB and neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effects",
          "context": "may produce antidepressant effects in several assays"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "block PDE4B1 function"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoforms",
          "context": "action against other PDE4 isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4a",
          "context": "encoded by the Pde4a and Pde4d genes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Pde4d",
          "context": "encoded by the Pde4a and Pde4d genes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 isoform",
          "context": "relationship of a PDE4 isoform with its specific interacting partners"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "interaction of PDE4B1 and DISC1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "interaction of PDE4B1 and DISC1"
        }
      ]
    },
    {
      "chunk_id": "5ba3b2ede0dcd3c835ceb6b158ad9c97",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "acrodysostosis",
          "context": "patients with acrodysostosis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D mutations"
        },
        {
          "entity_type": "Disease",
          "entity_name": "mental retardation",
          "context": "significant mental retardation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PRKAR1A",
          "context": "PRKAR1A mutations"
        },
        {
          "entity_type": "Disease",
          "entity_name": "behavioral disorders",
          "context": "have behavioral disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "intellectual disorders",
          "context": "intellectual disorders in PDE4D acrodysostosis patients"
        },
        {
          "entity_type": "Disease",
          "entity_name": "skeletal abnormalities",
          "context": "skeletal abnormalities"
        },
        {
          "entity_type": "Disease",
          "entity_name": "intellectual disability",
          "context": "involving intellectual disability"
        },
        {
          "entity_type": "Disease",
          "entity_name": "syndromes",
          "context": "additional PDE4D-mutant syndromes"
        },
        {
          "entity_type": "Disease",
          "entity_name": "CNS",
          "context": "affecting the CNS"
        }
      ]
    },
    {
      "chunk_id": "b1b140f1f4a4d4a112216692c8f52169",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "acrodysostosis",
          "context": "CNS phenotypes in the acrodysostosis patients"
        },
        {
          "entity_type": "Disease",
          "entity_name": "acrodysostosis",
          "context": "murine models of the acrodysostosis mutations"
        },
        {
          "entity_type": "Disease",
          "entity_name": "skeletal abnormalities",
          "context": "rat, which has skeletal abnormalities reminiscent of acrodysostosis"
        },
        {
          "entity_type": "Disease",
          "entity_name": "acrodysostosis",
          "context": "skeletal abnormalities reminiscent of acrodysostosis"
        }
      ]
    },
    {
      "chunk_id": "72b259bd416a82bf31182848ae564380",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 enzymes",
          "context": "Cellular functions of PDE4 enzymes."
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cyclic nucleotide phosphodiesterases",
          "context": "Cyclic nucleotide phosphodiesterases in health and disease."
        },
        {
          "entity_type": "Disease",
          "entity_name": "disease",
          "context": "Cyclic nucleotide phosphodiesterases in health and disease."
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP phosphodiesterase-4 (PDE4)",
          "context": "Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR1",
          "context": "requires interfaces located in both the UCR1 and catalytic unit domains."
        },
        {
          "entity_type": "Compound",
          "entity_name": "catalytic unit domains",
          "context": "requires interfaces located in both the UCR1 and catalytic unit domains."
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-responsive element-binding protein",
          "context": "mutation of the cAMP-responsive element-binding protein."
        },
        {
          "entity_type": "Effect",
          "entity_name": "Deficient long-term memory",
          "context": "Deficient long-term memory in mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "beta-Arrestin2",
          "context": "beta-Arrestin2, interacting with phosphodiesterase 4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4",
          "context": "beta-Arrestin2, interacting with phosphodiesterase 4"
        },
        {
          "entity_type": "Effect",
          "entity_name": "regulates synaptic release probability",
          "context": "regulates synaptic release probability and presynaptic inhibition by opioids."
        },
        {
          "entity_type": "Effect",
          "entity_name": "presynaptic inhibition",
          "context": "regulates synaptic release probability and presynaptic inhibition by opioids."
        },
        {
          "entity_type": "Compound",
          "entity_name": "opioids",
          "context": "presynaptic inhibition by opioids."
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1-binding proteins",
          "context": "DISC1-binding proteins in neural development"
        },
        {
          "entity_type": "Disease",
          "entity_name": "schizophrenia",
          "context": "signalling and schizophrenia."
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
        },
        {
          "entity_type": "Compound",
          "entity_name": "NDE1",
          "context": "DISC1, PDE4B, and NDE1 at the centrosome and synapse."
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "PKA phosphorylation of NDE1 is DISC1/PDE4 dependent"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LIS1",
          "context": "modulates its interaction with LIS1 and NDEL1."
        },
        {
          "entity_type": "Compound",
          "entity_name": "NDEL1",
          "context": "modulates its interaction with LIS1 and NDEL1."
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "mental illness through DISC1."
        },
        {
          "entity_type": "Disease",
          "entity_name": "mental illness",
          "context": "theories of mental illness through DISC1."
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4",
          "context": "Expression of phosphodiesterase 4 is altered"
        },
        {
          "entity_type": "Disease",
          "entity_name": "autism",
          "context": "brains of subjects with autism."
        },
        {
          "entity_type": "Compound",
          "entity_name": "GEBR-7b",
          "context": "GEBR-7b, a novel PDE4D selective inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D selective inhibitor",
          "context": "GEBR-7b, a novel PDE4D selective inhibitor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "improves memory",
          "context": "selective inhibitor that improves memory in rodents"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "non-emetic doses",
          "context": "in rodents at non-emetic doses."
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ca2+/calmodulin-dependent protein kinase",
          "context": "histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain."
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4D (PDE4D)",
          "context": "Design of phosphodiesterase 4D (PDE4D) allosteric modulators"
        },
        {
          "entity_type": "Compound",
          "entity_name": "allosteric modulators",
          "context": "phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhancing cognition",
          "context": "allosteric modulators for enhancing cognition with improved safety."
        },
        {
          "entity_type": "Compound",
          "entity_name": "Roflumilast",
          "context": "Roflumilast in symptomatic chronic obstructive pulmonary disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic obstructive pulmonary disease",
          "context": "symptomatic chronic obstructive pulmonary disease: two randomised clinical trials."
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterases",
          "context": "activity of drugs that inhibit phosphodiesterases."
        },
        {
          "entity_type": "Compound",
          "entity_name": "drugs",
          "context": "activity of drugs that inhibit phosphodiesterases."
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "Regulation of cocaine reward by CREB."
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB",
          "context": "Regulation of cocaine reward by CREB."
        },
        {
          "entity_type": "Disease",
          "entity_name": "myxomas",
          "context": "The complex of myxomas, spotty pigmentation, and endocrine overactivity."
        },
        {
          "entity_type": "Disease",
          "entity_name": "spotty pigmentation",
          "context": "myxomas, spotty pigmentation, and endocrine overactivity."
        },
        {
          "entity_type": "Disease",
          "entity_name": "endocrine overactivity",
          "context": "spotty pigmentation, and endocrine overactivity."
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB",
          "context": "form of CREB-mediated long-term facilitation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "long-term facilitation",
          "context": "CREB-mediated long-term facilitation can be stabilized"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "autoinhibited conformation of PDE4."
        },
        {
          "entity_type": "Effect",
          "entity_name": "impairs hippocampal mossy fiber-CA3 long-term potentiation",
          "context": "Acute stress impairs hippocampal mossy fiber-CA3 long-term potentiation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhancing cAMP-specific phosphodiesterase 4 activity",
          "context": "by enhancing cAMP-specific phosphodiesterase 4 activity."
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-specific phosphodiesterase 4",
          "context": "enhancing cAMP-specific phosphodiesterase 4 activity."
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibition of phosphodiesterase-4 reverses memory deficits",
          "context": "Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4",
          "context": "Inhibition of phosphodiesterase-4 reverses memory deficits"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Abeta25\u201335 peptide",
          "context": "produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
        },
        {
          "entity_type": "Compound",
          "entity_name": "Abeta1\u201340 peptide",
          "context": "produced by Abeta25\u201335 or Abeta1\u201340 peptide in rats."
        }
      ]
    },
    {
      "chunk_id": "5325ed436231048a4e9d95074e49a554",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Disrupted-in-Schizophrenia 1 (DISC1)",
          "context": "Disrupted-in-Schizophrenia 1 (DISC1) regulates spines"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rac1",
          "context": "via Rac1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "spines of the glutamate synapse"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Schizophrenia",
          "context": "Disrupted-in-Schizophrenia 1 (DISC1)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "Rolipram in major depressive disorder"
        },
        {
          "entity_type": "Disease",
          "entity_name": "major depressive disorder",
          "context": "Rolipram in major depressive disorder"
        },
        {
          "entity_type": "Compound",
          "entity_name": "imipramine",
          "context": "comparative study with imipramine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "Is PDE4 too difficult a drug target?"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Oxidative stress",
          "context": "Oxidative stress employs phosphatidyl inositol 3-kinase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphatidyl inositol 3-kinase",
          "context": "employs phosphatidyl inositol 3-kinase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK",
          "context": "and ERK signalling pathways"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP phosphodiesterase-4D3 (PDE4D3)",
          "context": "activate cAMP phosphodiesterase-4D3 (PDE4D3)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ser239",
          "context": "phosphorylation at Ser239"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ser579",
          "context": "and Ser579"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-specific phosphodiesterase HSPDE4D3",
          "context": "cAMP-specific phosphodiesterase HSPDE4D3 mutants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "changes in rolipram inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "protein kinase A",
          "context": "protein kinase A phosphorylation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ser-54",
          "context": "phosphorylation of Ser-54"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MAP kinase ERK2",
          "context": "The MAP kinase ERK2 inhibits"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP-specific phosphodiesterase HSPDE4D3",
          "context": "inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic adenosine monophosphate",
          "context": "down-regulation of cyclic adenosine monophosphate concentrations"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "compartmentalised cAMP signalling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterases 4",
          "context": "Crystal structures of phosphodiesterases 4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterases 5",
          "context": "and 5 in complex with inhibitor"
        },
        {
          "entity_type": "Compound",
          "entity_name": "3-isobutyl-1-methylxanthine",
          "context": "inhibitor 3-isobutyl-1-methylxanthine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type 4 phosphodiesterase",
          "context": "structures of type 4 phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Protein kinase LKB1",
          "context": "Protein kinase LKB1 regulates"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B)",
          "context": "The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anti-depressant",
          "context": "by the anti-depressant rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B cAMP-specific phosphodiesterase, HSPDE4B3",
          "context": "human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Ameliorating effects",
          "context": "Ameliorating effects of rolipram"
        },
        {
          "entity_type": "Disease",
          "entity_name": "impairments of learning and memory",
          "context": "induced impairments of learning and memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "DISC1-dependent switch"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type IV phosphodiesterases",
          "context": "involvement of type IV phosphodiesterases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "in cocaine-induced sensitization"
        },
        {
          "entity_type": "Effect",
          "entity_name": "sensitization",
          "context": "cocaine-induced sensitization"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pERK",
          "context": "and subsequent pERK expression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Angelman ubiquitin ligase",
          "context": "Mutation of the Angelman ubiquitin ligase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "p53",
          "context": "increased cytoplasmic p53"
        },
        {
          "entity_type": "Disease",
          "entity_name": "deficits of contextual learning and long-term potentiation",
          "context": "deficits of contextual learning and long-term potentiation"
        }
      ]
    },
    {
      "chunk_id": "eadfaa71ec4c678090c108e64271b81d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase type IV isozymes",
          "context": "regulation of phosphodiesterase type IV isozymes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant drug treatment",
          "context": "antidepressant drug treatment"
        },
        {
          "entity_type": "Disease",
          "entity_name": "electroconvulsive seizure",
          "context": "by electroconvulsive seizure"
        },
        {
          "entity_type": "Compound",
          "entity_name": "N-methyl-D-aspartate",
          "context": "N-methyl-D-aspartate receptor-stimulated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "cAMP and cGMP by PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cGMP",
          "context": "cAMP and cGMP by PDE4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 phosphodiesterases",
          "context": "cGMP by PDE4 and PDE2 phosphodiesterases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE2 phosphodiesterases",
          "context": "PDE4 and PDE2 phosphodiesterases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DARPP-32",
          "context": "DARPP-32: an integrator of neurotransmission"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP phosphodiesterase",
          "context": "dunce cAMP phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP phosphodiesterases",
          "context": "related cAMP phosphodiesterases"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant administration",
          "context": "Chronic antidepressant administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-specific phosphodiesterase 4A",
          "context": "phosphodiesterase 4A and 4B isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-specific phosphodiesterase 4B",
          "context": "phosphodiesterase 4A and 4B isoforms"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GluR1",
          "context": "Regulation of GluR1 by the A-kinase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "A-kinase anchoring protein 79 (AKAP79)",
          "context": "A-kinase anchoring protein 79 (AKAP79)"
        },
        {
          "entity_type": "Disease",
          "entity_name": "long-term depression",
          "context": "shares properties with long-term depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Type IV phosphodiesterase inhibitor",
          "context": "The Type IV phosphodiesterase inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "inhibitor rolipram interferes"
        },
        {
          "entity_type": "Effect",
          "entity_name": "drug-induced conditioned place preference",
          "context": "drug-induced conditioned place preference"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Phosphodiesterase inhibition",
          "context": "Phosphodiesterase inhibition rescues chronic"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic cognitive deficits",
          "context": "rescues chronic cognitive deficits"
        },
        {
          "entity_type": "Disease",
          "entity_name": "traumatic brain injury",
          "context": "induced by traumatic brain injury"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Sleep deprivation",
          "context": "Sleep deprivation impairs cAMP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "impairs cAMP signalling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase inhibitors",
          "context": "Phosphodiesterase inhibitors facilitate memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "facilitate memory",
          "context": "inhibitors facilitate memory"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "from reward to addiction"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant activity",
          "context": "Potential antidepressant activity of rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "activity of rolipram and other selective"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors",
          "context": "cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "Rolipram, a novel antidepressant drug"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant drug",
          "context": "a novel antidepressant drug"
        },
        {
          "entity_type": "Disease",
          "entity_name": "hypothermia",
          "context": "reverses the hypothermia and hypokinesia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "hypokinesia",
          "context": "hypothermia and hypokinesia of monoamine-depleted"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "hypokinesia of monoamine-depleted mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine receptors",
          "context": "beyond postsynaptic monoamine receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4",
          "context": "subfamilies of phosphodiesterase-4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "inhibitors",
          "context": "selectivity of their inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Alpha2A-adrenoceptors",
          "context": "Alpha2A-adrenoceptors strengthen working memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "strengthen working memory",
          "context": "strengthen working memory networks"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-HCN channel",
          "context": "inhibiting cAMP-HCN channel signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "fluoxetine",
          "context": "Chronic fluoxetine stimulates maturation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "psychiatric disease",
          "context": "The psychiatric disease risk factors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DISC1",
          "context": "factors DISC1 and TNIK interact"
        },
        {
          "entity_type": "Compound",
          "entity_name": "TNIK",
          "context": "DISC1 and TNIK interact to regulate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 inhibitor",
          "context": "The phosphodiesterase-4 inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "inhibitor rolipram reverses Abeta-induced"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Abeta",
          "context": "reverses Abeta-induced cognitive impairment"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cognitive impairment",
          "context": "Abeta-induced cognitive impairment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroinflammatory responses",
          "context": "and neuroinflammatory and apoptotic responses"
        },
        {
          "entity_type": "Effect",
          "entity_name": "apoptotic responses",
          "context": "and apoptotic responses in rats"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4D splice variants",
          "context": "phosphodiesterase 4D splice variants knock-down"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like effects",
          "context": "produces antidepressant-like and cognition-enhancing effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognition-enhancing effects",
          "context": "and cognition-enhancing effects"
        }
      ]
    },
    {
      "chunk_id": "31ca7ff4d4dd1ba712802d2c39773761",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase-4D",
          "context": "Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "alleviates depressive-like behaviors",
          "context": "Phosphodiesterase-4D knock-down in the prefrontal cortex alleviates chronic unpredictable stress-induced depressive-like behaviors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "alleviates memory deficits",
          "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
        },
        {
          "entity_type": "Disease",
          "entity_name": "depressive-like behaviors",
          "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
        },
        {
          "entity_type": "Disease",
          "entity_name": "memory deficits",
          "context": "alleviates chronic unpredictable stress-induced depressive-like behaviors and memory deficits in mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterases",
          "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cGMP",
          "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "Influence of phosphodiesterases and cGMP on cAMP generation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phospholamban",
          "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "troponin I",
          "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5-HT receptor",
          "context": "phosphorylation of phospholamban and troponin I by 5-HT receptor activation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase type 4 inhibitor",
          "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram into the amygdala"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Administration of the phosphodiesterase type 4 inhibitor rolipram into the amygdala"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases recognition memory persistence",
          "context": "rolipram into the amygdala at a specific time interval after learning increases recognition memory persistence"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptors",
          "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphatase",
          "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
        },
        {
          "entity_type": "Compound",
          "entity_name": "kinase",
          "context": "Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "PDE4 inhibition enhances hippocampal synaptic plasticity in vivo"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhances hippocampal synaptic plasticity",
          "context": "PDE4 inhibition enhances hippocampal synaptic plasticity in vivo"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MK801",
          "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "rescues impairment of long-term potentiation",
          "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "rescues impairment of object recognition memory",
          "context": "rescues MK801-induced impairment of long-term potentiation and object recognition memory"
        },
        {
          "entity_type": "Disease",
          "entity_name": "psychosis",
          "context": "in an animal model of psychosis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 inhibitors",
          "context": "Effects of repeated treatment with phosphodiesterase-4 inhibitors on cAMP signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "phosphodiesterase-4 inhibitors on cAMP signaling, hippocampal cell proliferation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type 4 cyclic nucleotide phosphodiesterases (PDE4s)",
          "context": "hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "RACK1 signaling scaffold protein",
          "context": "The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP-specific phosphodiesterase PDE4D5 isoform",
          "context": "interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform"
        },
        {
          "entity_type": "Compound",
          "entity_name": "noradrenergic",
          "context": "Diminished noradrenergic stimulation reduces the activity of rolipram-sensitive"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP phosphodiesterase",
          "context": "reduces the activity of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Noradrenergic activity differentially regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP phosphodiesterase (PDE4)",
          "context": "regulates the expression of rolipram-sensitive, high-affinity cyclic AMP phosphodiesterase (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type 4A phosphodiesterase (PDE4A)",
          "context": "Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UBE3A",
          "context": "An autism-linked mutation disables phosphorylation control of UBE3A"
        },
        {
          "entity_type": "Disease",
          "entity_name": "autism",
          "context": "An autism-linked mutation disables phosphorylation control of UBE3A"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB",
          "context": "CREB as a memory modulator: induced expression of a dCREB2 activator isoform"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dCREB2",
          "context": "induced expression of a dCREB2 activator isoform enhances long-term memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhances long-term memory",
          "context": "dCREB2 activator isoform enhances long-term memory in Drosophila"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GSK-3beta",
          "context": "GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CRMP-2",
          "context": "GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "cAMP signal transduction in the heart: understanding spatial control"
        },
        {
          "entity_type": "Compound",
          "entity_name": "HCN pacemaker channels",
          "context": "agonist specificity of HCN pacemaker channels"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Results of a phase II study of the antidepressant effect of rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant effect",
          "context": "Results of a phase II study of the antidepressant effect of rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cyclic AMP-specific phosphodiesterase-4",
          "context": "Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant",
          "context": "Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Effects of rolipram on scopolamine-induced impairment of working and reference memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "scopolamine",
          "context": "Effects of rolipram on scopolamine-induced impairment of working and reference memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impairment of working and reference memory",
          "context": "scopolamine-induced impairment of working and reference memory in the radial-arm maze tests"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP-specific phosphodiesterase",
          "context": "Ontogeny of rolipram-sensitive, low-K(m), cyclic AMP-specific phosphodiesterase in rat brain"
        }
      ]
    },
    {
      "chunk_id": "230fb7606d5bc884b238dc6dc00da481",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram- sensitive"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP",
          "context": "cyclic AMP specific phosphodiesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase",
          "context": "cyclic AMP specific phosphodiesterase"
        },
        {
          "entity_type": "Effect",
          "entity_name": "noradrenergic lesions",
          "context": "Effects of noradrenergic lesions"
        },
        {
          "entity_type": "Effect",
          "entity_name": "sensitive",
          "context": "rolipram- sensitive"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP phosphodiesterase (PDE4)",
          "context": "Inhibition of cyclic AMP phosphodiesterase (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NMDA receptor",
          "context": "NMDA receptor antagonism"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibition",
          "context": "Inhibition of cyclic AMP phosphodiesterase"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reverses memory deficits",
          "context": "reverses memory deficits"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antagonism",
          "context": "NMDA receptor antagonism"
        },
        {
          "entity_type": "Disease",
          "entity_name": "memory deficits",
          "context": "reverses memory deficits"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D phosphodiesterase enzyme",
          "context": "deficient in the PDE4D phosphodiesterase enzyme"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant-like profile",
          "context": "Antidepressant-like profile"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reduced sensitivity",
          "context": "reduced sensitivity to rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamine",
          "context": "A glutamine switch mechanism"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nucleotide",
          "context": "nucleotide selectivity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterases",
          "context": "selectivity by phosphodiesterases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4 (PDE4) enzyme",
          "context": "Inhibition of the phosphodiesterase 4 (PDE4) enzyme"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MEK inhibitor U0126",
          "context": "infusion of the MEK inhibitor U0126"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "Effects of the novel PDE4 inhibitors MEM1018 and MEM1091"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MEM1018",
          "context": "novel PDE4 inhibitors MEM1018"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MEM1091",
          "context": "novel PDE4 inhibitors MEM1091"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory avoidance",
          "context": "inhibitory avoidance tests"
        },
        {
          "entity_type": "Compound",
          "entity_name": "beta adrenergic agonists",
          "context": "beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cyclic AMP PDE inhibitor rolipram",
          "context": "cyclic AMP PDE inhibitor rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antidepressant-like behavioral effects",
          "context": "antidepressant-like behavioral effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase-4 enzyme (PDE4)",
          "context": "phosphodiesterase-4 enzyme (PDE4)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant-like effects",
          "context": "Antidepressant-like effects of PDE4 inhibitors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phosphodiesterase 4B (PDE4B)",
          "context": "deficient in phosphodiesterase 4B (PDE4B)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Anxiogenic-like behavioral phenotype",
          "context": "Anxiogenic-like behavioral phenotype"
        },
        {
          "entity_type": "Compound",
          "entity_name": "type 4 phosphodiesterase (PDE4)",
          "context": "binding to type 4 phosphodiesterase (PDE4)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "piclamilast",
          "context": "using [3H]piclamilast"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibitor binding",
          "context": "Inhibitor binding to type 4 phosphodiesterase"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antidepressant-induced increase",
          "context": "Antidepressant-induced increase"
        },
        {
          "entity_type": "Effect",
          "entity_name": "noradrenergic function",
          "context": "dependence on noradrenergic and serotonergic function"
        },
        {
          "entity_type": "Effect",
          "entity_name": "serotonergic function",
          "context": "dependence on noradrenergic and serotonergic function"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Phosphodiesterase 4",
          "context": "Phosphodiesterase 4 inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "impairs cocaine-induced inhibitory synaptic plasticity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibition",
          "context": "Phosphodiesterase 4 inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impairs",
          "context": "inhibition impairs cocaine-induced inhibitory synaptic plasticity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory synaptic plasticity",
          "context": "cocaine-induced inhibitory synaptic plasticity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "conditioned place preference",
          "context": "conditioned place preference"
        }
      ]
    }
  ],
  "total_entities": 469,
  "extraction_date": "2026-02-01T08:46:30.751268+00:00"
}